A Detailed Analysis of the Hepatitis C Virus Testing Market Based on Rising HCV Prevalence, Developments in Diagnostics, and the Emphasis on Public Health Campaigns Promoting Early Detection and Treatment
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 190
Report ID: PMRREP33718
1. Executive Summary
1.1. Global Hepatitis C Virus (HCV) Testing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Technique Lifecycle Analysis
2.4. Hepatitis C Virus (HCV) Testing Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Technique
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
3.3.3.1. Immunoassays-based Hepatitis C Virus Testing
3.3.3.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
3.3.3.3. Other Hepatitis C Virus Testing Techniques
3.4. Market Attractiveness Analysis: Technique
3.5. Global Hepatitis C Virus (HCV) Testing Market Outlook: Test Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
3.5.3.1. HCV Antibody Testing
3.5.3.2. HCV Viral Load Testing
3.5.3.3. HCV Genotyping Testing
3.6. Market Attractiveness Analysis: Test Type
3.7. Global Hepatitis C Virus (HCV) Testing Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.7.3.1. Hospitals
3.7.3.2. Diagnostic Centers
3.7.3.3. Blood Donation Centers
3.8. Market Attractiveness Analysis: End User
4. Global Hepatitis C Virus (HCV) Testing Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Technique
5.3.3. By Test Type
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
5.5.1. Immunoassays-based Hepatitis C Virus Testing
5.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
5.5.3. Other Hepatitis C Virus Testing Techniques
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
5.6.1. HCV Antibody Testing
5.6.2. HCV Viral Load Testing
5.6.3. HCV Genotyping Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.7.1. Hospitals
5.7.2. Diagnostic Centers
5.7.3. Blood Donation Centers
5.8. Market Attractiveness Analysis
6. Europe Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Technique
6.3.3. By Test Type
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
6.5.1. Immunoassays-based Hepatitis C Virus Testing
6.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
6.5.3. Other Hepatitis C Virus Testing Techniques
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
6.6.1. HCV Antibody Testing
6.6.2. HCV Viral Load Testing
6.6.3. HCV Genotyping Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.7.1. Hospitals
6.7.2. Diagnostic Centers
6.7.3. Blood Donation Centers
6.8. Market Attractiveness Analysis
7. East Asia Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Technique
7.3.3. By Test Type
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
7.5.1. Immunoassays-based Hepatitis C Virus Testing
7.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
7.5.3. Other Hepatitis C Virus Testing Techniques
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
7.6.1. HCV Antibody Testing
7.6.2. HCV Viral Load Testing
7.6.3. HCV Genotyping Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.7.1. Hospitals
7.7.2. Diagnostic Centers
7.7.3. Blood Donation Centers
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Technique
8.3.3. By Test Type
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
8.5.1. Immunoassays-based Hepatitis C Virus Testing
8.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
8.5.3. Other Hepatitis C Virus Testing Techniques
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
8.6.1. HCV Antibody Testing
8.6.2. HCV Viral Load Testing
8.6.3. HCV Genotyping Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.7.1. Hospitals
8.7.2. Diagnostic Centers
8.7.3. Blood Donation Centers
8.8. Market Attractiveness Analysis
9. Latin America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Technique
9.3.3. By Test Type
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
9.5.1. Immunoassays-based Hepatitis C Virus Testing
9.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
9.5.3. Other Hepatitis C Virus Testing Techniques
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
9.6.1. HCV Antibody Testing
9.6.2. HCV Viral Load Testing
9.6.3. HCV Genotyping Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.7.1. Hospitals
9.7.2. Diagnostic Centers
9.7.3. Blood Donation Centers
9.8. Market Attractiveness Analysis
10. Middle East & Africa Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Technique
10.3.3. By Test Type
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
10.5.1. Immunoassays-based Hepatitis C Virus Testing
10.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
10.5.3. Other Hepatitis C Virus Testing Techniques
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
10.6.1. HCV Antibody Testing
10.6.2. HCV Viral Load Testing
10.6.3. HCV Genotyping Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.7.1. Hospitals
10.7.2. Diagnostic Centers
10.7.3. Blood Donation Centers
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Technique Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. OraSure Technologies, Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Technique
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Abbott Laboratories Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Technique
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Siemens Healthcare GmbH
11.3.3.1. Overview
11.3.3.2. Segments and Technique
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bio Rad Laboratories Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Technique
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
11.3.5.1. Overview
11.3.5.2. Segments and Technique
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bayer AG
11.3.6.1. Overview
11.3.6.2. Segments and Technique
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. QIAGEN N.V.
11.3.7.1. Overview
11.3.7.2. Segments and Technique
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Thermo Fisher Scientific Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Technique
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. BioGenex
11.3.9.1. Overview
11.3.9.2. Segments and Technique
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. AccuQuick,
11.3.10.1. Overview
11.3.10.2. Segments and Technique
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
11.3.11.1. Overview
11.3.11.2. Segments and Technique
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. STD Rapid Test Kits
11.3.12.1. Overview
11.3.12.2. Segments and Technique
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations